Construction Spending in

Washington

Washington's biopharmaceutical companies research and develop new treatments and cures that improve patient health while also contributing to U.S. economic health. These companies employ highly skilled union construction workers to build state-of-the-art research and manufacturing facilities to ensure infrastructure is built to exacting standards.

Construction Employment

Union Labor & Earnings, 2012–17

Pharmaceutical & Biotech

813,198

million

Labor Hours Demanded

(14 trades, installation, and maintenance)

323,250

Union Labor Hours (est)

(State union% in non-residential = 39.8%)

$30.79

Average Union Wage

(Union construction workers, 2017 dollars)

$10

million

Total Union Earnings (est.)

(Union hours times average wage)

Industry Analysis: Washington

Pharmaceutical Manufacturing (2017)

Firms

103

Firms

Employees

2,866

Employees

Annual Wages

$191

million

Annual Wages

Washington Construction Labor Hours by Trade

Pharmaceutical & Biotech, 2012–17

6,178

Installation

3,787

Maintenance

9,966

Total hours

Largest Construction Projects

Pharmaceutical & Biotech Manufacturing, 2012–17

Dendreon Corporation

Seattle Biopharmaceutical R&D Laboratory Addition

Seattle, WA

75,000,000

2011-2013

ZymoGenetics Incorporated

Bothell Pilot-Scale Microbial & Mammalian-Based APIS/Proteins Plant Upfit/Add

Bothell, WA

37,000,000

2013-2014

AstaReal Technologies Incorporated

Moses Lake Grassroot Anti-Inflammatory APIS Plant

Moses Lake, WA

34,000,000

2013-2014

Juno Therapeutics Incorporated

Seattle Cancer Immunotherapies R&D Laboratory Addition/Tenant Fit-Out

Seattle, WA

30,000,000

2016-2017

Juno Therapeutics Incorporated

Bothell Cell-Based Cancer Immunotherapies Plant Addition

Bothell, WA

10,000,000

2015-2016

Seattle Genetics Incorporated

Bothell Cancer Antibodies R&D Laboratory Building 5 Expansion

Bothell, WA

10,000,000

2016-2017

Novo Nordisk

Seattle Fairview Novo Nordisk Diabetes R&D Basement/Mezzanine Vivarium Fit-Out

Seattle, WA

7,000,000

2015-2015

Jubilant HollisterStier LLC

Spokane Parenteral Raw Material Production Plant Renovation

Spokane, WA

5,000,000

2012-2012

Dendreon Corporation

Seattle Biopharmaceutical R&D Laboratory Addition

Seattle, WA

Location

75,000,000

Project Value

2011-2013

Years

Take Action

Share the study results and spread the word about the connection between the biopharmaceutical industry and union construction workers in Washington!

You may be surprised by the connection between Washington's biopharmaceutical industry and union labor. A new study finds that from 2012-2017 America’s biopharmaceutical companies invested $401 million in infrastructure in the state, supporting more than 323,000 union labor hours. View Washington's labor-industry profile here: https://bit.ly/2zM930a

Washington's pharmaceutical companies and the building trades unions have a surprising relationship - a new study finds that from 2012-2017 biopharmaceutical companies invested $401 million in infrastructure in the state, supporting more than 323,000 union labor hours. View Washington's labor-industry profile here: https://bit.ly/2zM930a

A new study finds that from 2012-2017 Washington's biopharmaceutical companies invested $401 million in infrastructure in the state, supporting more than 323,000 union labor hours. Learn more: https://bit.ly/2zM930a